The streptococcal collagen-like protein-1 (Scl1) is a significant determinant for biofilm formation by group a Streptococcus
© Oliver-Kozup et al; licensee BioMed Central Ltd. 2011
Received: 24 October 2011
Accepted: 14 December 2011
Published: 14 December 2011
Group A Streptococcus (GAS) is a human-specific pathogen responsible for a number of diseases characterized by a wide range of clinical manifestations. During host colonization GAS-cell aggregates or microcolonies are observed in tissues. GAS biofilm, which is an in vitro equivalent of tissue microcolony, has only recently been studied and little is known about the specific surface determinants that aid biofilm formation. In this study, we demonstrate that surface-associated streptococcal collagen-like protein-1 (Scl1) plays an important role in GAS biofilm formation.
Biofilm formation by M1-, M3-, M28-, and M41-type GAS strains, representing an intraspecies breadth, were analyzed spectrophotometrically following crystal violet staining, and characterized using confocal and field emission scanning electron microscopy. The M41-type strain formed the most robust biofilm under static conditions, followed by M28- and M1-type strains, while the M3-type strains analyzed here did not form biofilm under the same experimental conditions. Differences in architecture and cell-surface morphology were observed in biofilms formed by the M1- and M41-wild-type strains, accompanied by varying amounts of deposited extracellular matrix and differences in cell-to-cell junctions within each biofilm. Importantly, all Scl1-negative mutants examined showed significantly decreased ability to form biofilm in vitro. Furthermore, the Scl1 protein expressed on the surface of a heterologous host, Lactococcus lactis, was sufficient to induce biofilm formation by this organism.
Overall, this work (i) identifies variations in biofilm formation capacity among pathogenically different GAS strains, (ii) identifies GAS surface properties that may aid in biofilm stability and, (iii) establishes that the Scl1 surface protein is an important determinant of GAS biofilm, which is sufficient to enable biofilm formation in the heterologous host Lactococcus. In summary, the GAS surface adhesin Scl1 may have an important role in biofilm-associated pathogenicity.
Microbial biofilm formation is an important virulence mechanism, which allows immune evasion and survival against antibiotic treatments [1, 2]. Many bacterial nosocomial infections are associated with biofilms formed on contaminated medical devices. Dispersal of biofilm has also been proposed to augment infection spread [3–8]. For group A Streptococcus (GAS), biofilm research is an emerging field and little is known about the specific surface determinants that aid in biofilm formation. GAS is characteristically associated with significant human morbidity and it is responsible for the clinically common superficial throat and skin infections, such as pharyngitis and impetigo, as well as invasive soft tissue and blood infections like necrotizing fasciitis and toxic shock syndrome . Although GAS biofilm has not been associated with implanted medical devices, tissue microcolonies of GAS encased in an extracellular matrix were demonstrated in human clinical specimens . Studies reported to date support the involvement of GAS surface components in biofilm formation, including the M and M-like proteins, hyaluronic acid capsule, pili and lipoteichoic acid [11–13]. As shown by Cho and Caparon , multiple genes are upregulated during biofilm formation and development, including the streptococcal collagen-like protein-1 (Scl1).
The scl1 gene encoding the Scl1 protein has been found in every GAS strain investigated and its transcription is positively regulated by Mga [14–18], indicating that Scl1 is co-expressed with a number of proven virulence factors. Structurally, the extracellular portion of Scl1 protein extends from the GAS surface as a homotrimeric molecule composed of distinct domains that include the most outward N-terminal variable (V) region and the adjacent collagen-like (CL) region composed of repeating GlyXaaYaa (GXY) sequence. The linker (L) region is close to the cell surface and contains a series of conserved direct repeats. The Scl1 protein can bind selected human extracellular matrix components  and cellular integrin receptors [20–22], as well as plasma components [23–27].
In this study, we investigated the importance of Scl1 in GAS biofilm using defined isogenic wild-type and scl1-inactivated mutant strains of GAS. We report that (i) the pathogenically diverse M41-, M28-, M3- and M1-type GAS wild-type strains have varying capacities to produce biofilm on an abiotic surface; (ii) Scl1 plays an important role during the main stages of biofilm formation with Scl1-negative mutants having an abrogated capacity for adhesion, microcolony formation and biofilm maturation; and (iii) variations in surface morphology as well as in extracellular matrix associated with bacterial cells suggest two distinct but plausible mechanisms that potentially stabilize bacterial microcolonies. We additionally show that expression of Scl1 in Lactococcus lactis is sufficient to support a biofilm phenotype. Overall, this work reveals a significant role for the Scl1 protein as a cell-surface component during GAS biofilm formation among pathogenically varying strains.
Wild-type GAS strains have heterogeneous capacity for biofilm formation on abiotic surfaces
The failure of M3-type strain MGAS315 to produce substantial cellular biomass in the above assay was intriguing because sequence analysis of the scl1.3 allele found in MGAS315 revealed the presence of a TAA stop codon in the 11th GXY repeat of the Scl1.3-CL region containing a total of 25 GXY triplets . This premature stop codon results in a truncated Scl1.3 variant composed of 102 amino acids (~11.4 kDa), which does not contain the cell wall-membrane (WM) associated region, thus, preventing it from anchoring to the bacterial cell surface (Figure 1b). This prompted us to investigate the biofilm formation by five additional M3-type strains, all harboring the same scl1.3 allele. Five additional M3-type strains, MGAS335, MGAS1313, MGAS2079, MGAS274 and MGAS158, all harboring the same scl1.3 allele  also produced poor biofilm under static conditions, as measured by crystal violet staining. Confocal laser scanning microscopy (CLSM) of three representative strains (MGAS315, MGAS2079, and MGAS158) corroborated results obtained from the crystal violet assay, indicating that these M3-type strains lack the ability to form appreciable biofilm structure. Our data suggest that the lack of capacity for biofilm-formation among M3-type GAS strains examined here might be correlated, at least in part, with lack of surface-attached Scl1.3 protein.
Microscopic evaluation reveals differences in biofilm surface morphology
GAS biofilms differ in production of bacterial-associated extracellular matrix
Scl1 protein significantly contributes to biofilm formation by GAS
Variations in GAS pathogenicity and capacity to form biofilm are driven by specific proteins and components present on the cell surface or are secreted by the organism. It has been shown that deletion of the M and M-like surface proteins or capsule, as well as increased expression of the secreted SpeB protease decreases biofilm formation dramatically for some strains of GAS [12, 33, 34]. Therefore, we investigated the role of Scl1 in biofilm formation by comparing biofilms formed by GAS WT and scl1-inactivated (Δscl1) mutant strains (Figure 4; Additional file 1: Figure S1a-f). Bacterial biomass was evaluated spectrophotometrically following crystal violet staining at 1, 6, 12, and 24 h time points, representing different stages of biofilm formation, and absorbance values rendered for the WT and Δscl1 isogenic mutant strains were compared. The M41Δscl1 mutant showed a 29-35% decrease in biofilm formation (the OD600 value obtained for the WT strain at each time point was considered 100%), which was sustained throughout all time points. This reduction was statistically significant at initial adherence (1 h), as well as during biofilm development (6-12 h) and at maturation (24 h) (Figure 4a; P ≤ 0.05 at 1 and 12 h, P ≤ 0.001 at 6 and 24 h). Complementation of Scl1.41 expression in the M41Δscl1 mutant (M41 C) restored its ability to form biofilm to WT levels. Similarly, the M28Δscl1 mutant had a significantly decreased capacity for biofilm formation in the range of 29-44% as compared to WT strain (Figure 4b; P ≤ 0.05 at 1 and 6 h, P ≤ 0.001 at 3, 12 and 24 h). Likewise, there was a statistically significant decrease in M1Δscl1 biofilm biomass by ~42-75% compared to the WT strain (Figure 4c; P ≤ 0.001 at 1-24 h). CLSM analysis of corresponding 24-h biofilms of these strains confirmed our crystal violet staining results at 24 h. The Δscl1 mutants had substantially decreased average biofilm thickness by more than 50% (mean values) as compared to the parental WT organisms (Figure 4d-f). While these low average biofilm thickness values measured for the M1Δscl41 (6 μM) and M28Δscl1 (5 μM) correspond to residual biofilms made by those mutants (Additional file 1: Figure S1a-d), by comparison, the M1Δscl1 (4 μM) was shown not to produce a continuous biofilm layer under these conditions (Additional file 1: Figure S1e-f). Our data support the hypothesis that the Scl1 protein plays an important functional role during GAS biofilm formation and that Scl1 contribution varies among GAS strains with different genetic backgrounds.
Scl1 expression affects surface hydrophobicity
Cell surface hydrophobicity of GAS strains
92.6 ± .86
85.2 ± 2.2
98.0 ± .31
80.3 ± .89
63.3 ± 3.2
94.3 ± .73
72.6 ± .62
Scl1 is sufficient to support biofilm formation in Lactococcus lactis
Cell surface hydrophobicity of Lactococcus strains
L. lactis 1363 WT
59.7 ± 7.2
L. lactis 1363::pJRS525
56.6 ± 5.5
L. lactis 1363::pSl230
82.0 ± 2.6
Group A Streptococcus strains vary because of the vast number of M-protein types, and this variation is associated with varying frequency of isolation and exacerbation of disease [40, 41]. The M41-, M28-, M3-, and M1-type strains selected for the current study represent a significant intraspecies diversity among clinical isolates of GAS. M41 GAS was a major causative agent of superficial skin infections [42–44], and strain MGAS6183, harboring the Scl1.41 protein, has been studied extensively [19, 21, 22]. M28-type GAS (strain MGAS6143) has historically been associated with puerperal fever and currently is responsible for extensive human infections world-wide . M1T1 GAS, represented by strain MGAS5005, is a globally disseminated clone responsible for both pharyngitis and invasive infections [46–48]. The M3-type strains of GAS cause a disproportionally large number of invasive GAS infections that are responsible for traumatic morbidity and death [49, 50].
Initial studies by Lembke et al. that characterized biofilm formation among various M types of GAS typically included several strains of the same M type [1, 28]. These studies reported a significant strain-to-strain variation in ability to form biofilms within each M type. Studies that followed compared biofilm formation by defined isogenic WT and mutant strains to assess the contribution of specific GAS surface components responsible for a biofilm phenotype, including M and M-like proteins, hyaluronic acid capsule, lipoteichoic acid, and pili [12, 13]. In the current study, we have assessed the role and contribution of the surface protein Scl1 in the ability to support biofilm formation by GAS strains of four distinct M types.
Recent advances in molecular mega- and pathogenomics has enabled the characterization of numerous M3-type strains with a single nucleotide resolution [51, 52]. Interestingly, all five M3-type strains MGAS158, 274, 315, 335, and 1313 that were originally used for scl1-gene sequencing , plus an additional strain MGAS2079 (not reported) harbor the same scl1.3 allele containing a null mutation that would result in secretion of a truncated Scl1.3-protein variant. Here, we demonstrate that these GAS strains do not form biofilm on an abiotic surface. Recently, bioinformatic screening of the sequences of ~250 invasive M3-type strains isolated globally, has led to the detection of this single nucleotide polymorphism that results in disruption of Scl1.3 protein (Steve Beres and Jim Musser, personal communication). Lembke et al. reported heterogeneous biofilm formation among four M3-type GAS strains examined over a 24, 48, and 72-h period . Biofilm was detected for one strain at a 48 h time point, on a fibrinogen-coated surface; however, it is not known whether this clinical isolate forms biofilm on abiotic surface, whether it expresses the truncated or full-length Scl1.3 protein, and whether it produces an unknown fibrinogen-binding protein, which could augment the attachment and biofilm formation. Therefore, additional studies are necessary to define the contributions of other biofilm-formation determinants in M3-type strains.
Inasmuch as, variation in biofilm formation among GAS isolates of the same M-type has been established, the molecular basis of this phenotypic variation is not known. Several GAS surface-associated and secreted components were shown to contribute to variation in biofilm [12, 13, 33]. In addition, transcription regulators, such as Mga, CovR, and Srv are likely to play substantial roles in GAS biofilm formation [11, 33] due to their transcriptional regulation of numerous genes. Therefore, it is logical to assume that the combination of genomic/proteomic make up, allelic polymorphisms, and transcription regulation all contribute to this phenomenon. In addition, discrepancies between in vitro data obtained with laboratory-stored strains and microcolony formation in vivo likely exist and add yet another unknown to the complexity of GAS biofilm/microcolony formation and its role in pathogenesis. Despite this complexity, the analyses involving isogenic strains of the same genetic background provide valuable information that allows assessment of the role and contribution of a given GAS component to biofilm formation.
The M1 MGAS5005 strain was shown to form biofilm in vitro and in experimental animals [8, 33, 53], and the present study demonstrates a significant role of Scl1.1 in this process. Likewise, the MGAS6183 strain, representing M41-type isolates often associated with pyoderma, produced a more robust biofilm biomass under the same experimental conditions and Scl1.41-deficient mutant was found to be an important determinant in this process. Similarly, Scl1.28 protein significantly contributes to a robust biofilm made by the M28-type strain MGAS6143. However, a recent study reported that another surface protein, designated AspA, found in M28-type GAS significantly contributed to biofilm formation . The ΔaspA isogenic mutant showed 60% reduction in biofilm formation. The strain MGAS6180, which they used, expresses the same Scl1.28 variant present in the MGAS6143 strain we used; our Scl1.28 mutant showed ~44% reduction in 24 h biofilm. We propose that several surface proteins contribute to biofilm formation by M28-type strains including proteins AspA and Scl1.28, and potentially, proteins F1/SfbI and F2 that are also present in these strains . This redundancy is likely responsible for the observed residual biofilms produced by the AspA- and Scl1.28-deficient mutants.
The observed heterogeneity in biofilm architecture of different GAS strains was previously observed by Lembke et al.  and was also documented in the current study using FESEM. In addition, here we report the differences in GAS-cell surface morphology and within cell-to-cell junctions in biofilms formed by M1- and M41-type strains. The structural and genetic determination of these differences is not known since M41 genome has not been sequenced, but may be associated with the presence of additional surface proteins, such as the F2 protein  encoded by prtf2 gene found in this strain . Even more striking was an observed difference in the amount of the extracellular material associated with each strain, referred to as BAEM (bacteria-associated extracellular matrix). It has been shown that extracellular matrix, also called glycocalyx, is produced by biofilm-forming bacteria. DNA, lipids, proteins , polysaccharides and dead cell debris  were identified in this matrix and for gram-positive bacteria, teichoic acids have also been detected [57, 58]. The exopolysaccharide component of the glycocalyx is detected using carbohydrate-binding lectins, such as concanavalin A (ConA) . Both FESEM analysis and ConA staining detected more BAEM associated with M1 biofilm compared to M41, which produced larger biofilm. These observations suggest that GAS biofilm is stabilized differently by different strains and that higher BAEM production does not necessarily pre-determine larger biofilm mass. Consequently, a combination of biofilm features rather than biofilm size alone may be more relevant to pathogenicity of a given GAS strain.
Diminished adherence and biofilm formation could be associated with changes in cell surface hydrophobicity  of the scl1 mutants. Indeed, the lack of Scl1 resulted in both decreased hydrophobicity and the ability to form biofilm, albeit in a somewhat disproportionate manner. A decrease in the hydrophobicity index by only ~8%, as compared to the wild type-strain, was measured for the M41Δscl1 mutant and this modest decrease was accompanied by a rather large reduction in biofilm formation capacity after 24 h by 30%. Greater decrease in cell-surface hydrophobicity was measured for the M1Δscl1 (~21%) and M28Δscl1 (~22%) mutants, which was accompanied by a significant loss in biofilm formation after 24 h by both isogenic strains by ~55% and ~41% (P ≤ 0.001 for each comparison), respectively. In addition, heterologous expression of Scl.41 in L. lactis increased hydrophobicity index of this organism to ~137% of the WT level, which was accompanied by significant increase in its ability to form biofilm. Similar observations have been reported for the M and M-like protein mutants that typically, but not always, exhibit concurrent loss of both biological features . For example, isogenic ΔMrp49 mutant had a non-significant drop in hydrophobicity (~2%) but significantly lower biofilm formation after 48 h by ~30%, whereas ΔEmm1 mutant lost ~78% hydrophobicity and ~44% biofilm formation capacity. In summary: (i) here we report that the Scl1 adhesin is also a hydrophobin with varying contribution to the overall surface hydrophobicity among GAS strains representing different M types and (ii) Scl1-associated surface hydrophobicity is likely to contribute to Scl1-mediated biofilm formation.
To test whether Scl1 alone could support biofilm formation, we used a heterologous L. lactis strain, which provides an expression system for membrane-bound proteins of gram- positive bacteria with LPXTG cell-wall anchoring motifs [39, 60–62], including the group A streptococcal M6 protein [38, 63]. In a recent study by Maddocks et al.  it was shown that heterologous expression of AspA GAS surface protein was able to induce a biofilm phenotype in L. lactis MG1363. We were also able to achieve a gain-of-function derivative of the L. lactis WT MG1363 strain, (MG1363::pSL230), displaying an altered phenotype associated with biofilm formation, as compared to wild-type parental and vector-only controls. These data support our current model that Scl1 protein is an important determinant of GAS biofilm formation.
In the present work, using pathogenically differing GAS strains, we have demonstrated three concepts. First, we have confirmed previous observations that biofilm formation is an innate property of GAS strains. The M41-type strain used formed a more robust biofilm when compared to M28-type strain as well as M1-type strain. Importantly, the highly invasive M3-type strains devoid of the surface-associated Scl1 also lack the ability to form biofilm. Secondly, the absence of surface-associated Scl1 decreases GAS-cell hydrophobicity suggesting that Scl1 plays a role on the GAS surface as a hydrophobin. Thirdly, we have established that the Scl1 protein is a significant determinant for GAS biofilm formation. This concept was further tested by the heterologous expression of Scl1 in Lactococcus, an organism found in dairy fermentation environments, enabling it to form biofilm. Altogether, these data underscore the importance of Scl1 in biofilm-associated regulation of GAS pathogenicity. Recently published work has shown that the recombinant Scl1 binds to the extracellular matrix components, cellular fibronectin and laminin . Our current research provides a foundation warranting additional investigation as to whether direct Scl1-ECM binding may promote GAS biofilm as a bridging mechanism within host tissues.
GAS strains and growth conditions
The wild-type GAS strains M41- MGAS6183, M1- MGAS5005, and M28-type MGAS6143, as well as their scl1-inactivated isogenic mutants and complemented M41Δscl1 mutant have been previously described [22, 27, 65]. In addition, a set of the wild-type M3-type GAS strains MGAS158, MGAS274, MGAS315, MGAS335, MGAS1313, and MGAS2079 was also used. GAS cultures were routinely grown on brain-heart infusion agar (BD Biosciences) and in Todd-Hewitt broth (BD Biosciences) supplemented with 0.2% yeast extract (THY medium) at 37°C in an atmosphere of 5% CO2-20% O2. Logarithmic phase cultures harvested at the optical density (600 nm) of about 0.5 (OD600 ~0.5) were used to prepare GAS inocula for biofilm analysis. Colony counts were verified by plating on tryptic soy agar with 5% sheep's blood (Remel). Lactococcus lactis subsp. cremoris strain MG1363 (provided by Dr. Anton Steen) were grown using M17 broth or agar media (Oxoid) supplemented with 0.5 M sucrose and 0.5% glucose (SGM17 media) at 30°C in an atmosphere of 5% CO2-20% O2.
Heterologous Scl1 expression in Lactococcus lactis
To obtain electrocompetent cells, 500 ml of SGM17 broth supplemented with 2% glycine was inoculated with an overnight culture and grown until OD600 ~0.4 was reached. Cells were harvested and washed twice with ice-cold solution A (0.5 M sucrose, 10% glycerol); cells were then re-suspended in solution A (1/1000 of original culture volume) and stored at -80°C . For transformation, cells were thawed on ice and mixed with 1 μl of DNA of the Scl1.41-expressing plasmid pSL230 or pJRS525-vector ; and transferred to a cold 1-mm electrode-gap cuvette. Cells were pulsed with 2.0 kV at 25 μF and 400 Ω. Immediately following, suspensions were mixed with 1 ml outgrowth medium (SGM17 broth supplemented with 20 mM MgCl2 and 2 mM CaCl2) and incubated for 2.5 h before plating on SGM17 agar supplemented with spectinomycin .
Molecular characterization of transformants
The pSL230 was detected in Lactococcus lactis MG1363 transformants by PCR amplification directly from bacterial colonies with scl1.41-gene specific primers 232up (5'-CTCCACAAAGAGTGATCAGTC) and 232rev (5'-TTAGTTGTTTTCTTTGCGTTT); pSL230 plasmid DNA was used as a positive control. PCR samples were analyzed on 1% agarose gel in Tris-acetate-EDTA buffer and stained with ethidium bromide. Inocula from colonies of L. lactis MG1363, as well as colonies harboring either pJRS525 vector or pSL230 construct were used in subsequent experiments.
Western blot analysis
Cell-wall extracts were prepared as previously described . Briefly, cells grown to OD600 ~0.4 were harvested, washed with TES (10 mM Tris, 1 mM EDTA, 25% Sucrose), re-suspended in TES-LMR (TES containing 1 mg/ml hen egg lysozyme, 0.1 mg/ml mutanolysin, 0.1 mg/ml RNAseA and 1 mM PMSF) and incubated at 37°C for 1 h. After centrifugation at 2500 g for 10 min, the supernatants were precipitated with ice-cold TCA (16% final) at -20°C overnight. Precipitates were rinsed thoroughly with ice-cold acetone and dissolved in 1× sample buffer at 250 μl per unit OD600. Samples were subjected to 10% SDS-PAGE, transferred to nitrocellulose, and probed with anti-P176 antiserum followed by goat anti-rabbit-HRP and detected employing chemiluminescent substrate (Pierce).
Bacterial cells were grown to mid-log phase (OD600 ~0.4), washed once with filtered DPBS containing 1% FBS and re-suspended in the same buffer. Five million cells were incubated with 1:400 dilution of primary reagents, either rabbit pre-bleed (control) or rabbit anti-P176 antiserum for 30 min on ice, washed with DPBS-FBS and then incubated with 1:200 dilution of second reagent donkey anti-rabbit-APC (Jackson ImmunoResearch) for 30 min on ice. After a final wash and re-suspension in DPBS-FBS, flow cytometric data were acquired with FACSCaliber (BD Biosciences) and analyzed employing FCS Express (De Novo Software).
Analysis of biofilm formation
Crystal violet staining assay
Biofilm formation was tested using tissue culture treated polystyrene 24-well plates. 1.5 ml of logarithmic-phase GAS or Lactococcus cultures were seeded without dilution into wells and incubated at 37°C for GAS and 30°C for Lactococcus in an atmosphere of 5% CO2-20% O2 according to indicated time points upon which medium was aspirated. Wells were washed with PBS and 500 μl of 1% crystal violet was added to each well, and incubated at room temperature for 30 min. Dye was then aspirated, wells were washed with PBS, and stain was solubilized with 500 μl of 100% ethanol. Spectrophotometric readings at OD600 were recorded for each sample per time point. Samples were analyzed in triplicate in at least three experiments.
Confocal laser scanning microscopy (CLSM)
To visualize GAS and L. lactis strains by CLSM, bacterial cells were transformed with a GFP-encoding plasmid, pSB027 . 15-mm glass cover slips were placed into 24-well tissue culture plate wells. Logarithmic-phase bacterial cultures were inoculated without dilution and grown for 24 h. Cover slips were rinsed with PBS and fixed with 3% paraformaldehyde at room temperature for 30 min. Biofilms present on cover slips were washed with PBS and mounted onto slides using Prolong Gold mounting media (Invitrogen). Confocal images were acquired using a 63×/1.40 Plan-Apochromat objective and a Zeiss LSM 510 laser scanning confocal on an AxioImager Z1 microscope. An orthogonal view of the Z-stacks was used to display and measure biofilm thickness using Zeiss LSM software. Ten representative images within a single experiment were used to calculate the average vertical thickness measured in micrometers.
To visualize extracellular matrix associated with GAS cells, 24-h biofilm samples were reacted with 100 μg of tetramethyl rhodamine isothiocyanate- (TRITC)-conjugated concanavalin A (TRITC-ConA) (Invitrogen) for 30 min at room temperature in the dark prior to mounting with Prolong Gold medium. An average of ten microscopic views within each sample was reviewed using the 63×/1.40 objective, as described above.
Field emission scanning electron microscopy (FESEM)
GAS biofilm samples were grown for 24 h on glass cover slips, washed with PBS, and fixed with 3% paraformaldehyde for 2 h and post-fixed in osmium tetroxide. Samples were next dehydrated in an ethanol gradient, dried using hexamethyldisalizane, mounted onto aluminum stubs and sputter-coated with gold/palladium. The samples were then imaged on a Hitachi S-4800 field emission scanning electron microscope.
Quantitation of hydrophobicity
A modified hexadecane method [12, 37, 68] was used to determine the cell hydrophobicity. Briefly, 5 ml of the logarithmic-phase GAS or Lactococcus cultures (OD600 ~0.5) were pelleted, washed and re-suspended in 5 ml of PBS. One ml of hexadecane was added, vortexed for 1 min and incubated for 10 min at 30°C. Mixtures were then vortexed for an additional 1 min and allowed to stand for 2 min for phase separation at room temperature. The absorbance of the lower aqueous phase was read at OD600 and compared against the PBS control. Actual hydrophobicity value was calculated using the following equation: Actual Value = [1-(A/Ao)] × 100, where A is OD600 value after hexadecane treatment and Ao is OD600 prior to hexadecane treatment.
Statistical significance was determined using a two-tailed paired Student's t-test. The results were considered statistically significant with P ≤ 0.05 (*) and P ≤ 0.001 (**).
We would like to thank Dr. Steen for providing the Lactococcus lactis subsp. cremoris strain MG1363. This work was supported in part by National Institutes and Health Grant AI50666 and by a research grant (RFDG) from the West Virginia University Research and Graduate Education (to S. L.). H. Oliver-Kozup was supported by a grant from the West Virginia Graduate Student Fellowship in Science, Technology, Engineering and Mathematics (STEM). Confocal microscopy experiments were performed in the West Virginia University Microscope Imaging Facility, which is supported in part by the Mary Babb Randolph Cancer Center and NIH grant P20 RR016440. We would like to acknowledge the assistance of the West Virginia University Flow Cytometry core facility which was supported in part by a grant P30 RR032138 from the National Institutes of Health. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the National Institute of Occupational Safety and Health.
- Conley J, Olson ME, Cook LS, Ceri H, Phan V, Davies HD: Biofilm formation by group a streptococci: is there a relationship with treatment failure?. J Clin Microbiol. 2003, 41 (9): 4043-4048. 10.1128/JCM.41.9.4043-4048.2003.PubMedPubMed CentralView Article
- Ogawa T, Terao Y, Okuni H, Ninomiya K, Sakata H, Ikebe K, Maeda Y, Kawabata S: Biofilm formation or internalization into epithelial cells enable Streptococcus pyogenes to evade antibiotic eradication in patients with pharyngitis. Microb Pathog. 2011, 51 (1-2): 58-68. 10.1016/j.micpath.2011.03.009.PubMedView Article
- Boles BR, Thoendel M, Singh PK: Genetic variation in biofilms and the insurance effects of diversity. Microbiology. 2005, 151 (Pt 9): 2816-2818.PubMedView Article
- Lauderdale KJ, Malone CL, Boles BR, Morcuende J, Horswill AR: Biofilm dispersal of community-associated methicillin-resistant Staphylococcus aureus on orthopedic implant material. J Orthop Res. 2010, 28 (1): 55-61.PubMed
- Kaplan JB, Meyenhofer MF, Fine DH: Biofilm growth and detachment of Actinobacillus actinomycetemcomitans. J Bacteriol. 2003, 185 (4): 1399-1404. 10.1128/JB.185.4.1399-1404.2003.PubMedPubMed CentralView Article
- Raad II, Fang X, Keutgen XM, Jiang Y, Sherertz R, Hachem R: The role of chelators in preventing biofilm formation and catheter-related bloodstream infections. Curr Opin Infect Dis. 2008, 21 (4): 385-392. 10.1097/QCO.0b013e32830634d8.PubMedView Article
- Wang R, Khan BA, Cheung GY, Bach TH, Jameson-Lee M, Kong KF, Queck SY, Otto M: Staphylococcus epidermidis surfactant peptides promote biofilm maturation and dissemination of biofilm-associated infection in mice. J Clin Invest. 2011, 121 (1): 238-248. 10.1172/JCI42520.PubMedPubMed CentralView Article
- Connolly KL, Roberts AL, Holder RC, Reid SD: Dispersal of group A streptococcal biofilms by the cysteine protease SpeB leads to increased disease severity in a murine model. PLoS ONE. 2011, 6 (4): e18984-10.1371/journal.pone.0018984.PubMedPubMed CentralView Article
- Cunningham MW: Pathogenesis of group A streptococcal infections. Clin Microbiol Rev. 2000, 13: 470-511. 10.1128/CMR.13.3.470-511.2000.PubMedPubMed CentralView Article
- Akiyama H, Morizane S, Yamasaki O, Oono T, Iwatsuki K: Assessment of Streptococcus pyogenes microcolony formation in infected skin by confocal laser scanning microscopy. J Dermatol Sci. 2003, 32 (3): 193-199. 10.1016/S0923-1811(03)00096-3.PubMedView Article
- Cho K, Caparon M: Patterns of virulence gene expression differ between biofilm and tissue communities of Streptococcus pyogenes. Mol Microbiol. 2005, 57 (6): 1545-1556. 10.1111/j.1365-2958.2005.04786.x.PubMedView Article
- Courtney HS, Ofek I, Penfound T, Nizet V, Pence MA, Kreikemeyer B, Podbielski A, Hasty DL, Dale JB: Relationship between expression of the family of M proteins and lipoteichoic acid to hydrophobicity and biofilm formation in Streptococcus pyogenes. PLoS ONE. 2009, 4 (1): e4166-10.1371/journal.pone.0004166.PubMedPubMed CentralView Article
- Manetti A, Zingaretti C, Falugi F, Capo S, Bombaci M, Bagnoli F, Gambellini G, Bensi G, Mora M, Edwards A, et al: Streptococcus pyogenes pili promote pharyngeal cell adhesion and biofilm formation. Mol Microbiol. 2007, 64 (4): 968-983. 10.1111/j.1365-2958.2007.05704.x.PubMedView Article
- Lukomski S, Nakashima K, Abdi I, Cipriano VJ, Ireland RM, Reid SD, Adams GG, Musser JM: Identification and characterization of the scl gene encoding a group A Streptococcus extracellular protein virulence factor with similarity to human collagen. Infect Immun. 2000, 68 (12): 6542-6553. 10.1128/IAI.68.12.6542-6553.2000.PubMedPubMed CentralView Article
- Lukomski S, Nakashima K, Abdi I, Cipriano VJ, Shelvin BJ, Graviss EA, Musser JM: Identification and characterization of a second extracellular collagen-like protein made by group A Streptococcus: control of production at the level of translation. Infect Immun. 2001, 69 (3): 1729-1738. 10.1128/IAI.69.3.1729-1738.2001.PubMedPubMed CentralView Article
- Rasmussen M, Eden A, Björck L: SclA, a novel collagen-like surface protein of Streptococcus pyogenes. Infect Immun. 2000, 68 (11): 6370-6377. 10.1128/IAI.68.11.6370-6377.2000.PubMedPubMed CentralView Article
- Almengor AC, McIver KS: Transcriptional activation of sclA by Mga requires a distal binding site in Streptococcus pyogenes. J Bacteriol. 2004, 186 (23): 7847-7857. 10.1128/JB.186.23.7847-7857.2004.PubMedPubMed CentralView Article
- Almengor AC, Walters MS, McIver KS: Mga is sufficient to activate transcription in vitro of sof-sfbX and other Mga-regulated virulence genes in the group A Streptococcus. J Bacteriol. 2006, 188 (6): 2038-2047. 10.1128/JB.188.6.2038-2047.2006.PubMedPubMed CentralView Article
- Caswell CC, Oliver-Kozup H, Han R, Lukomska E, Lukomski S: Scl1, the multifunctional adhesin of group A Streptococcus, selectively binds cellular fibronectin and laminin, and mediates pathogen internalization by human cells. FEMS Microbiol Lett. 2010, 303 (1): 61-68. 10.1111/j.1574-6968.2009.01864.x.PubMedPubMed CentralView Article
- Humtsoe JO, Kim JK, Xu Y, Keene DR, Höök M, Lukomski S, Wary KK: A streptococcal collagen-like protein interacts with the α2β1 integrin and induces intracellular signaling. J Biol Chem. 2005, 280 (14): 13848-13857. 10.1074/jbc.M410605200.PubMedView Article
- Caswell CC, Barczyk M, Keene DR, Lukomska E, Gullberg DE, Lukomski S: Identification of the first prokaryotic collagen sequence motif that mediates binding to human collagen receptors, integrins α2β1 and α11β1. J Biol Chem. 2008, 283 (52): 36168-36175. 10.1074/jbc.M806865200.PubMedPubMed CentralView Article
- Caswell CC, Lukomska E, Seo NS, Höök M, Lukomski S: Scl1-dependent internalization of group A Streptococcus via direct interactions with the α2β1 integrin enhances pathogen survival and re-emergence. Mol Microbiol. 2007, 64 (5): 1319-1331. 10.1111/j.1365-2958.2007.05741.x.PubMedView Article
- Gao Y, Liang C, Zhao R, Lukomski S, Han R: The Scl1 of M41-type group A Streptococcus binds the high-density lipoprotein. FEMS Microbiol Lett. 2010, 309 (1): 55-61.PubMedPubMed Central
- Påhlman LI, Marx PF, Morgelin M, Lukomski S, Meijers JCM, Herwald H: Thrombin-activatable fibrinolysis inhibitor binds to Streptococcus pyogenes by interacting with collagen-like proteins A and B. J Biol Chem. 2007, 282 (34): 24873-24881. 10.1074/jbc.M610015200.PubMedView Article
- Caswell C, Han R, Hovis K, Ciborowski P, Keene D, Marconi R, Lukomski S: The Scl1 protein of M6-type group A Streptococcus binds the human complement regulatory protein, factor H, and inhibits the alternative pathway of complement. Mol Microbiol. 2008, 67 (3): 584-596. 10.1111/j.1365-2958.2007.06067.x.PubMedView Article
- Reuter M, Caswell CC, Lukomski S, Zipfel PF: Binding of the human complement regulators CFHR1 and factor H by streptococcal collagen-like protein 1 (Scl1) via their conserved C termini allows control of the complement cascade at multiple levels. J Biol Chem. 2010, 285 (49): 38473-38485. 10.1074/jbc.M110.143727.PubMedPubMed CentralView Article
- Han R, Caswell CC, Lukomska E, Keene DR, Pawlowski M, Bujnicki JM, Kim JK, Lukomski S: Binding of the low-density lipoprotein by streptococcal collagen-like protein Scl1 of Streptococcus pyogenes. Mol Microbiol. 2006, 61 (2): 351-367. 10.1111/j.1365-2958.2006.05237.x.PubMedView Article
- Lembke C, Podbielski A, Hidalgo-Grass C, Jonas L, Hanski E, Kreikemeyer B: Characterization of biofilm formation by clinically relevant serotypes of group A streptococci. Appl Environ Microbiol. 2006, 72 (4): 2864-2875. 10.1128/AEM.72.4.2864-2875.2006.PubMedPubMed CentralView Article
- Lukomski S, Sreevatsan S, Amberg C, Reichardt W, Woischnik M, Podbielski A, Musser JM: Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly decreases mouse lethality of serotype M3 and M49 strains. J Clin Invest. 1997, 99: 2574-2580. 10.1172/JCI119445.PubMedPubMed CentralView Article
- Donlan RM: Biofilms: microbial life on surfaces. Emerg Infect Dis. 2002, 8 (9): 881-890.PubMedPubMed CentralView Article
- Kania RE, Lamers GE, Vonk MJ, Huy PT, Hiemstra PS, Bloemberg GV, Grote JJ: Demonstration of bacterial cells and glycocalyx in biofilms on human tonsils. Arch Otolaryngol Head Neck Surg. 2007, 133 (2): 115-121. 10.1001/archotol.133.2.115.PubMedView Article
- Maeyama R, Mizunoe Y, Anderson JM, Tanaka M, Matsuda T: Confocal imaging of biofilm formation process using fluoroprobed Escherichia coli and fluoro-stained exopolysaccharide. J Biomed Mater Res A. 2004, 70 (2): 274-282.PubMedView Article
- Doern CD, Roberts AL, Hong W, Nelson J, Lukomski S, Swords WE, Reid SD: Biofilm formation by group A Streptococcus: a role for the streptococcal regulator of virulence (Srv) and streptococcal cysteine protease (SpeB). Microbiology. 2009, 155 (Pt 1): 46-52.PubMedPubMed CentralView Article
- Buznach N, Dagan R, Greenberg D: Clinical and bacterial characteristics of acute bacterial conjunctivitis in children in the antibiotic resistance era. Pediatr Infect Dis J. 2005, 24 (9): 823-828. 10.1097/01.inf.0000178066.24569.98.PubMedView Article
- Wadstrom T, Schmidt KH, Kuhnemund O, Havlicek J, Köhler W: Comparative studies on surface hydrophobicity of streptococcal strains of group-a, group-B, group-C, group-D and group-G. J Gen Microbiol. 1984, 130 (Mar): 657-664.PubMed
- Grivetti LE, Ogle BM: Value of traditional foods in meeting macro- and micronutrient needs: the wild plant connection. Nutr Res Rev. 2000, 13 (1): 31-46. 10.1079/095442200108728990.PubMedView Article
- Pan WH, Li PL, Liu Z: The correlation between surface hydrophobicity and adherence of Bifidobacterium strains from centenarians' faeces. Anaerobe. 2006, 12 (3): 148-152. 10.1016/j.anaerobe.2006.03.001.PubMedView Article
- Piard JC, Hautefort I, Fischetti VA, Ehrlich SD, Fons M, Gruss A: Cell wall anchoring of the Streptococcus pyogenes M6 protein in various lactic acid bacteria. J Bacteriol. 1997, 179 (9): 3068-3072.PubMedPubMed Central
- Linares DM, Kok J, Poolman B: Genome sequences of Lactococcus lactis MG1363 (Revised) and NZ9000 and comparative physiological studies. J Bacteriol. 2010, 192 (21): 5806-5812. 10.1128/JB.00533-10.PubMedPubMed CentralView Article
- Whatmore AM, Kapur V, Sullivan DJ, Musser JM, Kehoe MA: Non-congruent relationships between variation in emm gene sequences and the population genetic structure of group A streptococci. Mol Microbiol. 1994, 14 (4): 619-631. 10.1111/j.1365-2958.1994.tb01301.x.PubMedView Article
- Bessen DE, Sotir CM, Readdy TL, Hollingshead SK: Genetic correlates of throat and skin isolates of group A streptococci. J Infect Dis. 1996, 173: 896-900. 10.1093/infdis/173.4.896.PubMedView Article
- Anthony BF: Streptococcal pyoderma. Streptococcal Infections. Edited by: Stevens DL, Kaplan EL. 2000, New York: Oxford University Press, 144-151.
- Anthony BF, Perlman LV, Wannamaker LW: Skin infections and acute nephritis in American Indian children. Pediatrics. 1967, 39 (2): 263-279.PubMed
- Top FH, Wannamaker LW, Maxted WR, Anthony BF: M antigens among group A streptococci isolated from skin lesions. J Exp Med. 1967, 126 (4): 667-685. 10.1084/jem.126.4.667.PubMedPubMed CentralView Article
- Green NM, Beres SB, Graviss EA, Allison JE, McGeer AJ, Vuopio-Varkila J, LeFebvre RB, Musser JM: Genetic diversity among type emm28 group A Streptococcus strains causing invasive infections and pharyngitis. J Clin Microbiol. 2005, 43 (8): 4083-4091. 10.1128/JCM.43.8.4083-4091.2005.PubMedPubMed CentralView Article
- Aziz R, Kotb M: Rise and persistence of global M1T1 clone of Streptococcus pyogenes. Emerg Infect Dis. 2008, 14 (10): 1511-1517. 10.3201/eid1410.071660.PubMedPubMed CentralView Article
- Aziz RK, Edwards RA, Taylor WW, Low DE, McGeer A, Kotb M: Mosaic prophages with horizontally acquired genes account for the emergence and diversification of the globally disseminated M1T1 clone of Streptococcus pyogenes. J Bacteriol. 2005, 187 (10): 3311-3318. 10.1128/JB.187.10.3311-3318.2005.PubMedPubMed CentralView Article
- Musser JM, Kapur V, Szeto J, Pan X, Swanson DS, Martin DR: Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: recent intercontinental spread of a subclone causing episodes of invasive disease. Infect Immun. 1995, 63 (3): 994-1003.PubMedPubMed Central
- Kaul R, McGeer A, Low DE, Green K, Schwartz B, Study OGAS, Simor AE: Population-based surveillance for group A streptococcal necrotizing fasciitis: clinical features, prognostic indicators, and microbiologic analysis of 77 cases. Am J Med. 1997, 103: 18-24. 10.1016/S0002-9343(97)00160-5.PubMedView Article
- Sharkawy A, Low DE, Saginur R, Gregson D, Schwartz B, Jessamine P, Green K, McGeer A: Severe group a streptococcal soft-tissue infections in Ontario: 1992-1996. Clin Infect Dis. 2002, 34 (4): 454-460. 10.1086/338466.PubMedView Article
- Beres SB, Sylva GL, Barbian KD, Lei B, Hoff JS, Mammarella ND, Liu M-Y, Smoot JC, Porcella SF, Parkins LD, et al: Genome sequence of a serotype M3 strain of group A Streptococcus: Phage-encoded toxins, the high-virulence phenotype, and clone emergence. Proc Natl Acad Sci USA. 2002, 99 (15): 10078-10083. 10.1073/pnas.152298499.PubMedPubMed CentralView Article
- Beres SB, Sylva GL, Sturdevant DE, Granville CN, Liu M, Ricklefs SM, Whitney AR, Parkins LD, Hoe NP, Adams GJ, et al: Genome-wide molecular dissection of serotype M3 group A Streptococcus strains causing two epidemics of invasive infections. Proc Natl Acad Sci USA. 2004, 101 (32): 11833-11838. 10.1073/pnas.0404163101.PubMedPubMed CentralView Article
- Roberts AL, Connolly KL, Doern CD, Holder RC, Reid SD: Loss of the group A Streptococcus regulator Srv decreases biofilm formation in vivo in an otitis media model of infection. Infect Immun. 2010, 78 (11): 4800-4808. 10.1128/IAI.00255-10.PubMedPubMed CentralView Article
- Maddocks SE, Wright CJ, Nobbs AH, Brittan JL, Franklin L, Stromberg N, Kadioglu A, Jepson MA, Jenkinson HF: Streptococcus pyogenes antigen I/II-family polypeptide AspA shows differential ligand-binding properties and mediates biofilm formation. Mol Microbiol. 2011, 81 (4): 1034-1049. 10.1111/j.1365-2958.2011.07749.x.PubMedPubMed CentralView Article
- Jaffe J, Natanson-Yaron S, Caparon MG, Hanski E: Protein F2, a novel fibronectin-binding protein from Streptococcus pyogenes, possesses two domains. Mol Microbiol. 1996, 21: 373-384. 10.1046/j.1365-2958.1996.6331356.x.PubMedView Article
- Branda SS, Gonzalez-Pastor JE, Dervyn E, Ehrlich SD, Losick R, Kolter R: Genes involved in formation of structured multicellular communities by Bacillus subtilis. J Bacteriol. 2004, 186 (12): 3970-3979. 10.1128/JB.186.12.3970-3979.2004.PubMedPubMed CentralView Article
- Gotz F: Staphylococcus and biofilms. Mol Microbiol. 2002, 43 (6): 1367-1378. 10.1046/j.1365-2958.2002.02827.x.PubMedView Article
- Nadell CD, Xavier JB, Foster KR: The sociobiology of biofilms. FEMS Microbiol Rev. 2009, 33 (1): 206-224. 10.1111/j.1574-6976.2008.00150.x.PubMedView Article
- Courtney HS, Dale JB, Hasty DL: Strategies for preventing group A streptococcal adhesion and infection. Handbook of Bacterial Adhesion: Principles, Methods, and Applications. Edited by: An YH, Friedman RJ. 2000, Totowa: Humana Press, Inc., 553-579.View Article
- Luo HL, Wan K, Wang HH: High-frequency conjugation system facilitates biofilm formation and pAM β1 transmission by Lactococcus lactis. Appl Environ Microb. 2005, 71 (6): 2970-2978. 10.1128/AEM.71.6.2970-2978.2005.View Article
- Gerber SD, Solioz M: Efficient transformation of Lactococcus lactis IL1403 and generation of knock-out mutants by homologous recombination. J Basic Microb. 2007, 47 (3): 281-286. 10.1002/jobm.200610297.View Article
- Que YA, Haefliger JA, Francioli P, Moreillon P: Expression of Staphylococcus aureus clumping factor A in Lactococcus lactis subsp. cremoris using a new shuttle vector. Infect Immun. 2000, 68 (6): 3516-3522. 10.1128/IAI.68.6.3516-3522.2000.PubMedPubMed CentralView Article
- Piard JC, JimenezDiaz R, Fischetti VA, Ehrlich SD, Gruss A: The M6 protein of Streptococcus pyogenes and its potential as a tool to anchor biologically active molecules at the surface of lactic acid, bacteria. Streptococci and the Host. 1997, 418: 545-550.View Article
- Xu Y, Keene DR, Bujnicki JM, Höök M, Lukomski S: Streptococcal Scl1 and Scl2 proteins form collagen-like triple helices. J Biol Chem. 2002, 277 (30): 27312-27318. 10.1074/jbc.M201163200.PubMedView Article
- Lukomski S, Hoe NP, Abdi I, Rurangirwa J, Kordari P, Liu M, Dou SJ, Adams GG, Musser JM: Nonpolar inactivation of the hypervariable streptococcal inhibitor of complement gene (sic) in serotype M1 Streptococcus pyogenes significantly decreases mouse mucosal colonization. Infect Immun. 2000, 68 (2): 535-542. 10.1128/IAI.68.2.535-542.2000.PubMedPubMed CentralView Article
- Holo H, Nes IF: High-frequency transformation, by electroporation, of Lactococcus lactis subsp. cremoris grown with glycine in osmotically stabilized media. Appl Environ Microbiol. 1989, 55 (12): 3119-3123.PubMedPubMed Central
- Cramer T, Yamanishi Y, Clausen BE, Forster I, Pawlinski R, Mackman N, Haase VH, Jaenisch R, Corr M, Nizet V, et al: HIF-1α is essential for myeloid cell-mediated inflammation. Cell. 2003, 112 (5): 645-657. 10.1016/S0092-8674(03)00154-5.PubMedPubMed CentralView Article
- Grivet M, Morrier JJ, Benay G, Barsotti O: Effect of hydrophobicity on in vitro streptococcal adhesion to dental alloys. J Mater Sci Mater Med. 2000, 11 (10): 637-642. 10.1023/A:1008913915399.PubMedView Article
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.